Factors associated with complications in ST-elevation myocardial infarction: a single-center experience.
Complications
Determinants
Frequency
STEMI
Sud Francilien Hospital Center
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
19 09 2023
19 09 2023
Historique:
received:
24
05
2023
accepted:
06
09
2023
medline:
21
9
2023
pubmed:
20
9
2023
entrez:
19
9
2023
Statut:
epublish
Résumé
ST-elevation myocardial infarction (STEMI) is a major public health problem. This study aimed to determine the prevalence and identify the determinants of STEMI-related complications in the Cardiology Intensive Care Unit of the Sud Francilien Hospital Center (SFHC). We retrospectively analyzed the data of 315 patients with STEMI aged ≥ 18 years. Logistic regression was used to identify factors independently associated with the occurrence of complications. Overall, 315 patients aged 61.7 ± 13.4 years, of whom 261 were men, had STEMI during the study period. The hospital frequency of STEMI was 12.7%. Arrhythmias and acute heart failure were the main complications. Age ≥ 75 years (adjusted odds ratio [aOR], 5.18; 95% confidence interval [CI], 3.92-8.75), hypertension (aOR, 3.38; 95% CI, 1.68-5.82), and cigarette smoking (aOR, 3.52; 95% CI, 1.69-7.33) were independent determinants of acute heart failure. Meanwhile, diabetes mellitus (aOR, 1.74; 95% CI, 1.09-3.37), history of atrial fibrillation (aOR, 2.79; 95% CI, 1.66-4.76), history of stroke or transient ischemic attack (aOR, 1.99; 95% CI, 1.31-2.89), and low high-density lipoprotein-cholesterol (HDL-C) levels (aOR, 3.70; 95% CI, 1.08-6.64) were independent determinants of arrhythmias. STEMI is a frequent condition at SFHC and is often complicated by acute heart failure and arrhythmias. Patients aged ≥ 75 years, those with hypertension or diabetes mellitus, smokers, those with a history of atrial fibrillation or stroke, and those with low HDL-C levels require careful monitoring for the early diagnosis and management of these complications.
Sections du résumé
BACKGROUND
ST-elevation myocardial infarction (STEMI) is a major public health problem. This study aimed to determine the prevalence and identify the determinants of STEMI-related complications in the Cardiology Intensive Care Unit of the Sud Francilien Hospital Center (SFHC).
METHODS
We retrospectively analyzed the data of 315 patients with STEMI aged ≥ 18 years. Logistic regression was used to identify factors independently associated with the occurrence of complications.
RESULTS
Overall, 315 patients aged 61.7 ± 13.4 years, of whom 261 were men, had STEMI during the study period. The hospital frequency of STEMI was 12.7%. Arrhythmias and acute heart failure were the main complications. Age ≥ 75 years (adjusted odds ratio [aOR], 5.18; 95% confidence interval [CI], 3.92-8.75), hypertension (aOR, 3.38; 95% CI, 1.68-5.82), and cigarette smoking (aOR, 3.52; 95% CI, 1.69-7.33) were independent determinants of acute heart failure. Meanwhile, diabetes mellitus (aOR, 1.74; 95% CI, 1.09-3.37), history of atrial fibrillation (aOR, 2.79; 95% CI, 1.66-4.76), history of stroke or transient ischemic attack (aOR, 1.99; 95% CI, 1.31-2.89), and low high-density lipoprotein-cholesterol (HDL-C) levels (aOR, 3.70; 95% CI, 1.08-6.64) were independent determinants of arrhythmias.
CONCLUSION
STEMI is a frequent condition at SFHC and is often complicated by acute heart failure and arrhythmias. Patients aged ≥ 75 years, those with hypertension or diabetes mellitus, smokers, those with a history of atrial fibrillation or stroke, and those with low HDL-C levels require careful monitoring for the early diagnosis and management of these complications.
Identifiants
pubmed: 37726694
doi: 10.1186/s12872-023-03498-z
pii: 10.1186/s12872-023-03498-z
pmc: PMC10510166
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
468Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
pubmed: 33309175
pmcid: 7755038
Barquera S, Pedroza-Tobias A, Medina C, Hernandez-Barrera L, Bibbins-Domingo K, Lozano R, et al. Global overview of the Epidemiology of Atherosclerotic Cardiovascular Disease. Arch Med Res. 2015;46(5):328–38.
pubmed: 26135634
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 update: a Report from the American Heart Association. Circulation. 2017;135(10):e146–e603.
pubmed: 28122885
pmcid: 5408160
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25.
pubmed: 28527533
pmcid: 5491406
Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi S, AlKatheeri R, et al. Global epidemiology of Ischemic Heart Disease: results from the global burden of Disease Study. Cureus. 2020;12(7):e9349.
pubmed: 32742886
pmcid: 7384703
India State-Level Disease Burden Initiative CVDC. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the global burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1339–e51.
Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of Acute Coronary Syndromes: a review. JAMA. 2022;327(7):662–75.
pubmed: 35166796
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126(16):2020–35.
pubmed: 22923432
Ishihara M, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, et al. Long-term outcomes of Non-ST-Elevation myocardial infarction without creatine kinase Elevation- the J-MINUET study. Circ J. 2017;81(7):958–65.
pubmed: 28320999
Terkelsen CJ, Lassen JF, Norgaard BL, Gerdes JC, Jensen T, Gotzsche LB, et al. Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Eur Heart J. 2005;26(1):18–26.
pubmed: 15615795
Puymirat E, Simon T, Cayla G, Cottin Y, Elbaz M, Coste P, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-Month Outcomes over a period of 20 years in the FAST-MI program (French Registry of Acute ST-Elevation or Non-ST-Elevation myocardial infarction) 1995 to 2015. Circulation. 2017;136(20):1908–19.
pubmed: 28844989
Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, et al. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of myocardial infarction from 1990 to 2006. Am Heart J. 2008;156(6):1026–34.
pubmed: 19032996
Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, et al. Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J. 2006;27(7):789–95.
pubmed: 16464911
Vernon ST, Coffey S, D’Souza M, Chow CK, Kilian J, Hyun K, et al. ST-Segment-Elevation myocardial infarction (STEMI) patients without Standard Modifiable Cardiovascular risk factors-how common are they, and what are their outcomes? J Am Heart Assoc. 2019;8(21):e013296.
pubmed: 31672080
pmcid: 6898813
Bouisset F, Ruidavets JB, Dallongeville J, Moitry M, Montaye M, Biasch K et al. Comparison of short- and long-term prognosis between ST-Elevation and Non-ST-Elevation myocardial infarction. J Clin Med. 2021;10(2).
Gale CP, Allan V, Cattle BA, Hall AS, West RM, Timmis A, et al. Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). Heart. 2014;100(7):582–9.
pubmed: 24436220
Jernberg T, Johanson P, Held C, Svennblad B, Lindback J, Wallentin L, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305(16):1677–84.
pubmed: 21521849
Belle L, Cayla G, Cottin Y, Coste P, Khalife K, Labeque JN, et al. French Registry on Acute ST-elevation and non-ST-elevation myocardial infarction 2015 (FAST-MI 2015). Design and baseline data. Arch Cardiovasc Dis. 2017;110(6–7):366–78.
pubmed: 28647465
Menozzi A. An overview on STEMI. Minerva Cardioangiol. 2018;66(4):391.
pubmed: 29975021
Bueno H, Martin-Asenjo R. Acute heart failure after STEMI. Still a problem, still an opportunity for improving care quality. Int J Cardiol. 2017;248:274–5.
pubmed: 28942875
Jones DE, Braun M, Kassop D. Acute Coronary Syndrome: common complications and conditions that mimic ACS. FP Essent. 2020;490:29–34.
pubmed: 32150366
Frampton J, Ortengren AR, Zeitler EP. Arrhythmias after Acute myocardial infarction. Yale J Biol Med. 2023;96(1):83–94.
pubmed: 37009192
pmcid: 10052595
Figueras J, Alcalde O, Barrabes JA, Serra V, Alguersuari J, Cortadellas J, et al. Changes in hospital mortality rates in 425 patients with acute ST-elevation myocardial infarction and cardiac rupture over a 30-year period. Circulation. 2008;118(25):2783–9.
pubmed: 19064683
Tran HV, Ash AS, Gore JM, Darling CE, Kiefe CI, Goldberg RJ. Twenty-five year trends (1986–2011) in hospital incidence and case-fatality rates of ventricular tachycardia and ventricular fibrillation complicating acute myocardial infarction. Am Heart J. 2019;208:1–10.
pubmed: 30471486
Murray CSG, Zamora C, Shitole SG, Christa P, Lee UJ, Bortnick AE, et al. Race-ethnic differences of ST-Elevation myocardial infarction: findings from a New York Health System Registry. Ethn Dis. 2022;32(3):193–202.
pubmed: 35909638
pmcid: 9311301
Ya’qoub L, Lemor A, Dabbagh M, O’Neill W, Khandelwal A, Martinez SC, et al. Racial, ethnic, and sex disparities in patients with STEMI and cardiogenic shock. JACC Cardiovasc Interv. 2021;14(6):653–60.
pubmed: 33736772
Karthikeyan T, Raja M, Radha D, Gaur TA, Geetha J, Sakthivadivel V. Risk factors and inflammatory markers in acute coronary syndrome-ST elevation myocardial infarction (STEMI). Horm Mol Biol Clin Investig. 2023.
Vicent L, Velasquez-Rodriguez J, Valero-Masa MJ, Diez-Delhoyo F, Gonzalez-Saldivar H, Bruna V, et al. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion. Int J Cardiol. 2017;248:46–50.
pubmed: 28942880
Rossello X, Huo Y, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol. 2017;245:27–34.
pubmed: 28750924
Machta S, Gauthier V, Ferrieres J, Montaye M, Huo Yung Kai S, Gbokou S, et al. Comparison of clinical profiles and care for patients with incident versus recurrent acute coronary syndromes in France: data from the MONICA registries. PLoS ONE. 2022;17(2):e0263589.
pubmed: 35157710
pmcid: 8843220
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77.
pubmed: 28886621
Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med. 2012;60(6):766–76.
pubmed: 22939607
Cravens MG, Ali SF, Gibbs MA, Littmann L. Real-time validation of the Sgarbossa and modified Sgarbossa criteria in intermittent left bundle branch block. J Electrocardiol. 2020;63:24–7.
pubmed: 33045460
Berberich AJ, Hegele RA. A Modern Approach to Dyslipidemia. Endocr Rev. 2022;43(4):611–53.
pubmed: 34676866
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
pubmed: 4337382
Ahmadi SA, Boroumand MA, Gohari-Moghaddam K, Tajik P, Dibaj SM. The impact of low serum triglyceride on LDL-cholesterol estimation. Arch Iran Med. 2008;11(3):318–21.
pubmed: 18426324
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.
pubmed: 34447992
Julian DG, Valentine PA, Miller GG. Disturbances of rate, rhythm and conduction in Acute myocardial infarction: a prospective study of 100 consecutive unselected patients with the aid of Electrocardiographic Monitoring. Am J Med. 1964;37:915–27.
pubmed: 14246092
Jewitt DE, Balcon R, Raftery EB, Oram S. Incidence and management of supraventricular arrhythmias after acute myocardial infarction. Lancet. 1967;2(7519):734–8.
pubmed: 4167249
Stock E, Goble A, Sloman G. Assessment of arrhythmias in myocardial infarction. Br Med J. 1967;2(5554):719–23.
pubmed: 6025977
pmcid: 1841757
Dubois C, Smeets JP, Demoulin JC, Pierard L, Foidart G, Henrard L, et al. Incidence, clinical significance and prognosis of ventricular fibrillation in the early phase of myocardial infarction. Eur Heart J. 1986;7(11):945–51.
pubmed: 3792355
Adgey AA, Allen JD, Geddes JS, James RG, Webb SW, Zaidi SA, et al. Acute phase of myocardial infarction. Lancet. 1971;2(7723):501–4.
pubmed: 4105660
Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356(23):2388–98.
pubmed: 17554120
Patil PR, Khatana P, Patil DR. Incidence of cardiac arrhythmias in patients with acute myocardial infarction during the first 48 hours of the onset of chest pain. Int J Adv Med. 2017;4(4):1144–49.
Terkelsen CJ, Sørensen JT, Kaltoft AK, Nielsen SS, Thuesen L, Bøtker H-E, et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2009;104(12):1641–6.
pubmed: 19962468
Bloch Thomsen PE, Jons C, Raatikainen MP, Moerch Joergensen R, Hartikainen J, Virtanen V, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification after Acute myocardial infarction (CARISMA) study. Circulation. 2010;122(13):1258–64.
pubmed: 20837897
Tatli E, Alicik G, Buturak A, Yilmaztepe M, Aktoz M. Arrhythmias following revascularization procedures in the course of acute myocardial infarction: are they indicators of reperfusion or ongoing ischemia? The Scientific World Journal. 2013;2013.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–83.
pubmed: 11907286
Zhao J, He F, Hu DY, Ding RJ, Yu XJ, Gou JJ, et al. [Types and risk factors of arrhythmia on young patients with acute coronary syndrome in Henan province]. Zhonghua xin xue guan bing za zhi. 2013;41(7):572–6.
pubmed: 24284184
Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Eur Heart J Acute Cardiovasc Care. 2015;4(4):386.
pubmed: 25178689
Podolecki T, Lenarczyk R, Kowalczyk J, Jedrzejczyk-Patej E, Chodor P, Mazurek M, et al. Prognostic significance of Complex Ventricular Arrhythmias complicating ST-Segment Elevation myocardial infarction. Am J Cardiol. 2018;121(7):805–9.
pubmed: 29452692
Shah JA, Naz F, Kumar R, Hassan M, Shah G, Ahmed K, et al. Incidence of Cardiac Arrhythmias in Acute myocardial infarction patients undergoing primary percutaneous coronary intervention and Associated Outcomes during the first 24 hours. Cureus. 2021;13(1):e12599.
pubmed: 33585089
pmcid: 7871363
Petrosyan H, Hayrapetyan H, Torozyan S, Tsaturyan A, Tribunyan S. In-hospital complications in acute ST-elevation myocardial infarction depending on renal function. Herzschrittmacherther Elektrophysiol. 2021;32(3):359–64.
pubmed: 34255141
Bezzina CR, Pazoki R, Bardai A, Marsman RF, de Jong J, Blom MT, et al. Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nat Genet. 2010;42(8):688–91.
pubmed: 20622880
pmcid: 3966292
de la Perez RA, Swieszkowski SP, Cintora FM, Aladio JM, Papini CM, Matsudo M, et al. Neuroendocrine System Regulatory Mechanisms: Acute Coronary syndrome and stress hyperglycaemia. Eur Cardiol. 2018;13(1):29–34.
Nito I, Waspadji S, Harun S, Markum HM. Correlation between cortisol levels and myocardial infarction mortality among intensive coronary care unit patients during first seven days in hospital. Acta Med Indones. 2004;36(1):8–14.
pubmed: 15931696
Pena Escobar JA, Aung M, Amin S, Gulraiz A, Gandhi FR, Malik BH. Pathogenesis of ventricular arrhythmias and its effect on long-term prognosis in patients with Takotsubo Cardiomyopathy. Cureus. 2020;12(10):e11171.
pubmed: 33262908
pmcid: 7689872
Boonsom W, Ratanasumawong K, Hutayanon P, Tungsabutra W. Implications of diabetes mellitus in patients with STEMI: data from Thai ACS Registry. J Med Assoc Thai. 2007;90(Suppl 1):12–20.
pubmed: 18431882
Junttila MJ, Kiviniemi AM, Lepojarvi ES, Tulppo M, Piira OP, Kentta T, et al. Type 2 diabetes and coronary artery disease: preserved ejection fraction and sudden cardiac death. Heart Rhythm. 2018;15(10):1450–6.
pubmed: 30274618
Yeung CY, Lam KS, Li SW, Lam KF, Tse HF, Siu CW. Sudden cardiac death after myocardial infarction in type 2 diabetic patients with no residual myocardial ischemia. Diabetes Care. 2012;35(12):2564–9.
pubmed: 22875229
pmcid: 3507604
Junttila MJ, Barthel P, Myerburg RJ, Makikallio TH, Bauer A, Ulm K, et al. Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. Heart Rhythm. 2010;7(10):1396–403.
pubmed: 20682359
Guckel D, Sohns C, Sommer P. [Rhythm and metabolic control]. Herz. 2022;47(5):410–8.
pubmed: 35849125
Al Kury LT, Chacar S, Alefishat E, Khraibi AA, Nader M. Structural and electrical remodeling of the Sinoatrial Node in Diabetes: New Dimensions and Perspectives. Front Endocrinol (Lausanne). 2022;13:946313.
pubmed: 35872997
Karam BS, Chavez-Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):120.
pubmed: 28962617
pmcid: 5622555
Coumel P, Leenhardt A. Mental activity, adrenergic modulation, and cardiac arrhythmias in patients with heart disease. Circulation. 1991;83(4 Suppl):II58–70.
pubmed: 2009630
Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114(9):1500–15.
pubmed: 24763467
pmcid: 4043633
Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104(24):2886–91.
pubmed: 11739301
Liu YB, Wu CC, Lee CM, Chen WJ, Wang TD, Chen PS, et al. Dyslipidemia is associated with ventricular tachyarrhythmia in patients with acute ST-segment elevation myocardial infarction. J Formos Med Assoc. 2006;105(1):17–24.
pubmed: 16440066
Boudi FB, Kalayeh N, Movahed MR. High-density lipoprotein cholesterol (HDL-C) levels independently correlates with Cardiac Arrhythmias and Atrial Fibrillation. J Intensive Care Med. 2020;35(5):438–44.
pubmed: 29421988
Karabacak M, Kahraman F, Sert M, Celik E, Adali MK, Varol E. Increased plasma monocyte chemoattractant protein-1 levels in patients with isolated low high-density lipoprotein cholesterol. Scand J Clin Lab Invest. 2015;75(4):327–32.
pubmed: 25797068
Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20(4):457–64.
pubmed: 6059183
Cahill TJ, Kharbanda RK. Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: mechanisms, incidence and identification of patients at risk. World J Cardiol. 2017;9(5):407–15.
pubmed: 28603587
pmcid: 5442408
Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, et al. Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock. ESC Heart Fail. 2018;5(3):292–301.
pubmed: 29424484
pmcid: 5933968
Xu J, Yang Y. Integrated Gene expression profiling analysis reveals potential molecular mechanisms and candidate biomarkers for early risk stratification and prediction of STEMI and Post-STEMI Heart failure patients. Front Cardiovasc Med. 2021;8:736497.
pubmed: 34957234
pmcid: 8702808
Carrick D, Haig C, Maznyczka AM, Carberry J, Mangion K, Ahmed N, et al. Hypertension, Microvascular Pathology, and Prognosis after an Acute Myocardial Infarction. Hypertension. 2018;72(3):720–30.
pubmed: 30012869
Haig C, Carrick D, Carberry J, Mangion K, Maznyczka A, Wetherall K, et al. Current smoking and prognosis after Acute ST-Segment Elevation myocardial infarction: New Pathophysiological Insights. JACC Cardiovasc Imaging. 2019;12(6):993–1003.
pubmed: 30031700
pmcid: 6547246
Dokoupil J, Hrecko J, Cermakova E, Adamcova M, Pudil R. Characteristics and outcomes of patients admitted for acute heart failure in a single-centre study. ESC Heart Fail. 2022;9(4):2249–58.
pubmed: 35388622
pmcid: 9288775
Acar B, Ozeke O, Unal S, Karakurt M, Kara M, Kirbas O, et al. Change in left ventricular systolic function in patients with ST elevation myocardial infarction: evidence for smoker’s paradox or pseudo-paradox? Indian Heart J. 2016;68(6):816–20.
pubmed: 27931553
pmcid: 5143820